These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 26163201

  • 1. The Pathophysiology and Treatment of Osteoporosis.
    Drake MT, Clarke BL, Lewiecki EM.
    Clin Ther; 2015 Aug; 37(8):1837-50. PubMed ID: 26163201
    [Abstract] [Full Text] [Related]

  • 2. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M, Levancini M.
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [Abstract] [Full Text] [Related]

  • 3. Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Hansen L, Petersen KD, Eriksen SA, Gerstoft F, Vestergaard P.
    Osteoporos Int; 2017 Jan; 28(1):321-328. PubMed ID: 27475930
    [Abstract] [Full Text] [Related]

  • 4. Perspectives on osteoporosis therapies.
    Cairoli E, Zhukouskaya VV, Eller-Vainicher C, Chiodini I.
    J Endocrinol Invest; 2015 Mar; 38(3):303-11. PubMed ID: 25577263
    [Abstract] [Full Text] [Related]

  • 5. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E.
    Osteoporos Int; 2003 Mar; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [Abstract] [Full Text] [Related]

  • 6. Parkinson's disease and osteoporosis.
    van den Bos F, Speelman AD, Samson M, Munneke M, Bloem BR, Verhaar HJ.
    Age Ageing; 2013 Mar; 42(2):156-62. PubMed ID: 23132148
    [Abstract] [Full Text] [Related]

  • 7. Skeletal response to treatment with teriparatide (TPD) after bisphosphonate in post-menopausal women with osteoporosis and a high prevalence of secondary risk factors in real-life setting of a metabolic bone clinic; effect of age and vitamin D status.
    Mok J, Brown C, Moore AEB, Min SS, Hampson G.
    Endocr Res; 2018 Aug; 43(3):195-202. PubMed ID: 29652557
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Osteoporosis in premenopausal women.
    Langdahl BL.
    Curr Opin Rheumatol; 2017 Jul; 29(4):410-415. PubMed ID: 28394826
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Indications to teriparatide treatment in patients with osteoporosis.
    Rizzoli R, Kraenzlin M, Krieg MA, Mellinghoff HU, Lamy O, Lippuner K.
    Swiss Med Wkly; 2011 Jul; 141():w13297. PubMed ID: 22057669
    [Abstract] [Full Text] [Related]

  • 16. Use of teriparatide in osteoporotic fracture patients.
    Collinge C, Favela J.
    Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
    [Abstract] [Full Text] [Related]

  • 17. Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.
    Ebeling PR, Russell RG.
    Int J Clin Pract; 2003 Oct; 57(8):710-8. PubMed ID: 14627183
    [Abstract] [Full Text] [Related]

  • 18. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD, Hanley DA, Lorraine JK, Yu M.
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.